Endoscopic Management of Gastroparesis

Abstract

Gastroparesis is a complex pathology that continues to evolve in its diagnosis and treatment. Throughout the years, we have gained a more thorough understanding of normal and pathologic physiology of the stomach, which has allowed us to garner different approaches to the treatment of gastroparesis. We aim to evaluate the current literature regarding diagnosis and treatment of gastroparesis with a specific focus on the endoscopic management of this pathology.

Keywords

gastroparesis - management of gastroparesis - endoscopic management

Publikationsverlauf

Eingereicht: 12. Januar 2021

Angenommen: 03. März 2021

Artikel online veröffentlicht:
06. Mai 2021

• References

• 1 Schemann M, Rohn M, Michel K. Motor control of the stomach. Eur Rev Med Pharmacol Sci 2008; 12 (Suppl. 01) 41-51
• 2 Jung HK, Choung RS, Locke III GR. et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136 (04) 1225-1233
• 3 Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998; 43 (11) 2398-2404
• 4 Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med 1958; 48 (04) 797-812
• 5 Parkman HP, Yates K, Hasler WL. et al; National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology 2011; 140 (01) 101-115
• 6 Hasler WL, Wilson LA, Parkman HP. et al; NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Bloating in gastroparesis: severity, impact, and associated factors. Am J Gastroenterol 2011; 106 (08) 1492-1502
• 7 Choi KM, Gibbons SJ, Nguyen TV. et al. Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology 2008; 135 (06) 2055-2064 , 2064.e1–2064.e2
• 8 Camilleri M, Chedid V, Ford AC. et al. Gastroparesis. Nat Rev Dis Primers 2018; 4 (01) 41
• 9 Hasler WL. Gastroparesis: pathogenesis, diagnosis and management. Nat Rev Gastroenterol Hepatol 2011; 8 (08) 438-453
• 10 Abell TL, Camilleri M, Donohoe K. et al; American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 2008; 103 (03) 753-763
• 11 Ghoos YF, Maes BD, Geypens BJ. et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993; 104 (06) 1640-1647
• 12 Szarka LA, Camilleri M, Vella A. et al. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol 2008; 6 (06) 635-643.e1
• 13 Shin AS, Camilleri M. Diagnostic assessment of diabetic gastroparesis. Diabetes 2013; 62 (08) 2667-2673
• 14 Kunkel DC, Clarke JO. Murky waters for diagnosis of gastroparesis. Clin Gastroenterol Hepatol 2019; 17 (09) 1724-1725
• 15 Lee AA, Rao S, Nguyen LA. et al. Validation of diagnostic and performance characteristics of the wireless motility capsule in patients with suspected gastroparesis. Clin Gastroenterol Hepatol 2019; 17 (09) 1770-1779.e2
• 16 Camilleri M, Hasler WL, Parkman HP, Quigley EM, Soffer E. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 1998; 115 (03) 747-762
• 17 Malik Z, Sankineni A, Parkman HP. Assessing pyloric sphincter pathophysiology using EndoFLIP in patients with gastroparesis. Neurogastroenterol Motil 2015; 27 (04) 524-531
• 18 Gourcerol G, Tissier F, Melchior C. et al. Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation. Aliment Pharmacol Ther 2015; 41 (04) 360-367
• 19 Revicki DA, Rentz AM, Dubois D. et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18 (01) 141-150
• 20 Revicki DA, Camilleri M, Kuo B. et al. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther 2009; 30 (06) 670-680
• 21 Revicki DA, Rentz AM, Dubois D. et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 2004; 13 (04) 833-844
• 22 Parrish CR, Yoshida CM. Nutrition intervention for the patient with gastroparesis: an update. Pract Gastroenterol 2005; 29: 29
• 23 Sarosiek I, Davis B, Eichler E, McCallum RW. Surgical approaches to treatment of gastroparesis: gastric electrical stimulation, pyloroplasty, total gastrectomy and enteral feeding tubes. Gastroenterol Clin North Am 2015; 44 (01) 151-167
• 24 Bouras EP, Vazquez Roque MI, Aranda-Michel J. Gastroparesis: from concepts to management. Nutr Clin Pract 2013; 28 (04) 437-447
• 25 Wang CP, Kao CH, Chen WK, Lo WY, Hsieh CL. A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis. J Altern Complement Med 2008; 14 (07) 833-839
• 26 Kim KH, Lee MS, Choi TY, Kim TH. Acupuncture for symptomatic gastroparesis. Cochrane Database Syst Rev 2018; 12 (12) CD009676
• 27 Gottfried-Blackmore A, Adler EP, Fernandez-Becker N, Clarke J, Habtezion A, Nguyen L. Open-label pilot study: non-invasive vagal nerve stimulation improves symptoms and gastric emptying in patients with idiopathic gastroparesis. Neurogastroenterol Motil 2020; 32 (04) e13769
• 28 Shada AL, Dunst CM, Pescarus R. et al. Laparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesis. Surg Endosc 2016; 30 (04) 1326-1332
• 29 Toro JP, Lytle NW, Patel AD. et al. Efficacy of laparoscopic pyloroplasty for the treatment of gastroparesis. J Am Coll Surg 2014; 218 (04) 652-660
• 30 Hibbard ML, Dunst CM, Swanström LL. Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement. J Gastrointest Surg 2011; 15 (09) 1513-1519
• 31 Abell T, McCallum R, Hocking M. et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003; 125 (02) 421-428
• 32 Arthur LE, Slattery L, Richardson W. Tailored approach to gastroparesis significantly improves symptoms. Surg Endosc 2018; 32 (02) 977-982
• 33 de Csepel J, Goldfarb B, Shapsis A, Goff S, Gabriel N, Eng HM. Electrical stimulation for gastroparesis. Gastric motility restored. Surg Endosc 2006; 20 (02) 302-306
• 34 McCallum RW, Sarosiek I, Parkman HP. et al. Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis. Neurogastroenterol Motil 2013; 25 (10) 815-e636
• 35 Timratana P, El-Hayek K, Shimizu H, Kroh M, Chand B. Laparoscopic gastric electrical stimulation for medically refractory diabetic and idiopathic gastroparesis. J Gastrointest Surg 2013; 17 (03) 461-470
• 36 Davis BR, Sarosiek I, Bashashati M, Alvarado B, McCallum RW. The long-term efficacy and safety of pyloroplasty combined with gastric electrical stimulation therapy in gastroparesis. J Gastrointest Surg 2017; 21 (02) 222-227
• 37 Tetangco EGP, Harrell S, Abboud R. et al. GOO due to gastric stimulator electrode migration: add this to your DDx of gastroparesis exacerbation: 1890. Am J Gastroenterol 2018; 113: S1072-S1073
• 38 Abell TL, Johnson WD, Kedar A. et al. A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis. Gastrointest Endosc 2011; 74 (03) 496-503.e3
• 39 Deb S, Tang SJ, Abell TL. et al. An endoscopic wireless gastrostimulator (with video). Gastrointest Endosc 2012; 75 (02) 411-415 , 415.e1
• 40 Lee AM, Fuchs KH, Varga G. et al. Sleeve gastrectomy for treatment of delayed gastric emptying-indications, technique, and results. Langenbecks Arch Surg 2020; 405 (01) 107-116
• 41 Landreneau JP, Strong AT, El-Hayek K, Kroh MD, Rodriguez JH. Gastrectomy versus stomach left in situ with Roux-en-Y reconstruction for the treatment of gastroparesis. Surg Endosc 2020; 34 (04) 1847-1855
• 42 Wiesel PH, Schneider R, Dorta G, Blum AL, Gillet M, Michetti P. Botulinum toxin for refractory postoperative pyloric spasm. Endoscopy 1997; 29 (02) 132
• 43 Miller LS, Szych GA, Kantor SB. et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002; 97 (07) 1653-1660
• 44 Lacy BE, Zayat EN, Crowell MD, Schuster MM. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 2002; 97 (06) 1548-1552
• 45 Arts J, van Gool S, Caenepeel P, Verbeke K, Janssens J, Tack J. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther 2006; 24 (04) 661-667
• 46 Bromer MQ, Friedenberg F, Miller LS, Fisher RS, Swartz K, Parkman HP. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005; 61 (07) 833-839
• 47 Gupta P, Rao SS. Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report. Gastrointest Endosc 2002; 56 (05) 770-772
• 48 Arts J, Holvoet L, Caenepeel P. et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26 (09) 1251-1258
• 49 Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103 (02) 416-423
• 50 Bai Y, Xu MJ, Yang X. et al. A systematic review on intrapyloric botulinum toxin injection for gastroparesis. Digestion 2010; 81 (01) 27-34
• 51 Clarke JO, Sharaiha RZ, Kord Valeshabad A, Lee LA, Kalloo AN, Khashab MA. Through-the-scope transpyloric stent placement improves symptoms and gastric emptying in patients with gastroparesis. Endoscopy 2013; 45 (Suppl 2 UCTN): E189-E190
• 52 Khashab MA, Besharati S, Ngamruengphong S. et al. Refractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation (with video). Gastrointest Endosc 2015; 82 (06) 1106-1109
• 53 Khashab MA, Stein E, Clarke JO. et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc 2013; 78 (05) 764-768
• 54 Khashab MA, Ngamruengphong S, Carr-Locke D. et al. Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc 2017; 85 (01) 123-128
• 55 Mekaroonkamol P, Shah R, Cai Q. Outcomes of per oral endoscopic pyloromyotomy in gastroparesis worldwide. World J Gastroenterol 2019; 25 (08) 909-922
• 56 Spadaccini M, Maselli R, Chandrasekar VT. et al. Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis: a systematic review of early outcomes with pooled analysis. Gastrointest Endosc 2020; 91 (04) 746-752.e5
• 57 Mohan BP, Chandan S, Jha LK. et al. Clinical efficacy of gastric per-oral endoscopic myotomy (G-POEM) in the treatment of refractory gastroparesis and predictors of outcomes: a systematic review and meta-analysis using surgical pyloroplasty as a comparator group. Surg Endosc 2019
• 58 Aghaie Meybodi M, Qumseya BJ, Shakoor D. et al. Efficacy and feasibility of G-POEM in management of patients with refractory gastroparesis: a systematic review and meta-analysis. Endosc Int Open 2019; 7 (03) E322-E329
• 59 Uemura KL, Chaves D, Bernardo WM, Uemura RS, de Moura DTH, de Moura EGH. Peroral endoscopic pyloromyotomy for gastroparesis: a systematic review and meta-analysis. Endosc Int Open 2020; 8 (07) E911-E923
• 60 Gonzalez JM, Benezech A, Vitton V, Barthet M. G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome. Aliment Pharmacol Ther 2017; 46 (03) 364-370
• 61 Brown AM, Pryor AD, Docimo Jr S. Per oral pyloromyotomy utilizing a lesser curvature approach: how we do it. Surg Endosc 2020; 34 (11) 5168-5171